Pulmonary Pharmacology & Therapeutics

Papers
(The median citation count of Pulmonary Pharmacology & Therapeutics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis80
Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers36
Shedding light on vitamin D in tuberculosis: A comprehensive review of clinical trials and discrepancies32
Celebrating the appointment of Mario Cazzola as Honorary Editor of Pulmonary Pharmacology & Therapeutics27
Improvement of asthma control in adult patients using extrafine inhaled beclomethasone/formoterol fixed combination as maintenance therapy as well as maintenance and reliever therapy – CONTROL study27
Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)23
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients22
S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function22
The inflammatory regulation of TRPA1 expression in human A549 lung epithelial cells21
Pharmacokinetic variability of CFTR modulators from standard and alternative regimens21
Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin d20
Editorial Board19
Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation19
Editorial Board17
Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis16
Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets16
Relative bioavailability of budesonide/glycopyrrolate/formoterol fumarate triple therapy delivered using next generation propellants with low global warming potential16
Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes16
The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study14
Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea12
FTO regulates the proliferation and apoptosis of pulmonary artery smooth muscle cells through m6A demethylation modification12
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis12
Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis12
Mesenchymal stromal cells-based therapy in a murine model of elastase-induced emphysema: Simvastatin as a potential adjuvant in cellular homing12
Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma12
Ferroptosis mediates airway epithelial E-cadherin dysfunction in LPS-induced acute lung injury11
Unveiling the protective role of sevoflurane in video-assisted thoracoscopic surgery associated-acute lung injury: Inhibition of ferroptosis11
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts11
Impact on beclometasone dipropionate pharmacokinetics when switching to a low global warming potential propellant in a pressurised metered-dose inhaler11
Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant10
Efficacy and safety of sequential combination therapy for pulmonary arterial hypertension: A meta-analysis of Randomized-Controlled Trials10
Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial10
Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score10
Ensifentrine approval: A milestone in the treatment of COPD9
Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis9
Editorial Board9
The incidence and prognosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders of the lung related to methotrexate: A retrospective study9
Editorial Board9
The era of multiple biologics: Is combination and switching an option in the management of severe asthma?9
Editorial Board9
Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-α8
Editorial Board8
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality8
Scoping review: The state of research on cryptogenic organizing pneumonia therapeutics8
Corrigendum to “Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients 8
The wonders of stem cells therapeutic application towards chronic obstructive pulmonary disease8
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma8
Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea7
Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany7
Inflammatory and contractile profile in LPS-challenged equine isolated bronchi: Evidence for IL-6 as a potential target against AHR in equine asthma7
Remote preconditioning combined with nebulized budesonide alleviate lipopolysaccharide induced acute lung injury via regulating HO-1 and NF-κB in rats7
Strongyloides venezuelensis-derived venestatin ameliorates asthma pathogenesis by suppressing receptor for advanced glycation end-products-mediated signaling7
β-sitosterol targets glucocorticoid receptor to reduce airway inflammation and remodeling in allergic asthma7
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study7
Protective effects of adipose-derived biogenic nanoparticles on the pulmonary microvascular endothelial barrier in mice with ventilator-induced lung injury via the TRPV4/ROCK1 signalling pathway7
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan7
Association between pre-ICU aspirin administration and ARDS mortality in the MIMIC-IV database: A cohort study6
The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysis6
Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics6
Editorial Board6
Repeated doses of captopril induce airway hyperresponsiveness by modulating the TRPV1 receptor in rats6
Tyvaso DPI: Drug-device characteristics and patient clinical considerations6
Activating transcription factor 6 in the endothelial context6
Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma6
Safety and tolerability of inhaled antibiotics in patients with bronchiectasis6
ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway6
Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia6
Corrigendum to “Bleomycin induced lung fibrosis increases work of breathing in the mouse” [Pulm. Pharmacol.Therapeut. 25 (2012) 281-285]5
The immunomodulatory effects of macrolide antibiotics in respiratory disease5
Tolerability and efficacy of second-line antifibrotics in patients with idiopathic pulmonary fibrosis5
Which LABA/LAMA should be chosen in COPD patients in real life?5
Serum dipeptidyl peptidase-4 and eosinophil cationic protein levels in patients of bronchial asthma5
SIRT3 alleviates sepsis-induced acute lung injury by inhibiting pyroptosis via regulating the deacetylation of FoxO3a5
HDAC8-inhibitor PCI-34051-induced exosomes inhibit human bronchial smooth muscle cell proliferation via miR-381-3p mediated TGFB35
Experimental modeling of pulmonary fibrosis and combined emphysema in mice using repeated doses of bleomycin and cigarette smoke extract5
Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway5
Icaritin protects against airway inflammation by inhibiting the TLR4/NF-κB pathway in vivo and in vitro5
Treatment of respiratory viral infections through inhalation therapeutics: Challenges and opportunities5
Editorial Board5
Pulmonary drug delivery for acute respiratory distress syndrome5
Targeted inhibition of IDO1 by Kushenol A enhances radiosensitivity in non-small cell lung cancer4
Effect of roflumilast on airway remodeling in asthmatic mice exposed to or not exposed to cigarette smoke: Comparison with the effect of dexamethasone4
Dexmedetomidine reduces IL-4 and IgE expression through downregulation of theTLR4/NF-κB signaling pathway to alleviate airway hyperresponsiveness in OVA mice4
Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients4
Medication use in people with cystic fibrosis before and after modulator therapy4
Comparative biochemical efficacy analysis of an alpha1-proteinase inhibitor (Glassia®) in patients with alpha-1 antitrypsin deficiency4
Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis4
Demethyleneberberine alleviates Pseudomonas aeruginosa-induced acute pneumonia by inhibiting the AIM2 inflammasome and oxidative stress4
Are short courses of antibiotic therapy as effective as standard courses for COPD exacerbations? A systematic review and meta-analysis4
The compound artemisinin-hydroxychloroquine ameliorates bleomycin-induced pulmonary fibrosis in rats by inhibiting TGF-β1/Smad2/3 signaling pathway4
Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate4
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting4
Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial4
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension4
Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study4
Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRPα expression4
Efficacy and safety of selexipag, an oral prostacyclin receptor agonist for the treatment of pulmonary hypertension: A meta-analysis3
Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL33
The low global warming potential propellant HFA-152a does not induce bronchoconstriction or impair mucociliary clearance3
Inhaled vs. intravenous vasodilators in perioperative pulmonary hypertension during chest surgery using cardiopulmonary bypass: A systematic review and meta-analysis3
The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers3
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome3
Sildenafil for idiopathic pulmonary fibrosis: A systematic review and meta-analysis3
Corrigendum to “Presence and function of β-adrenergic receptors in primary equine bronchial epithelia cells” [Pulm Pharmacol Ther. (2020 Apr) 61 101897] DOI: 10.1016/j.pupt.2020.1018973
Up-regulation of PPAR-γ involved in the therapeutic effect of icariin on cigarette smoke-induced inflammation3
Impact of beta blockers on resting respiratory rate in older adults: A cross-sectional study3
A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells3
Impacts of deficiency in vitamin D derivatives on disease severity in adult bronchial asthma patients3
Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat3
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia3
Effect of centrally and peripherally acting GABAB agonism on the healthy human cough reflex3
Effect of functional principle, delivery technique, and connection used on aerosol delivery from different nebulizers: An in-vitro study3
IRE1α/XBP-1 promotes β-catenin signaling activation of airway epithelium in lipopolysaccharide-induced acute lung injury3
0.033438920974731